These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

80 related items for PubMed ID: 9086428

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Clinical significance of low levels of second-trimester maternal serum human chorionic gonadotropin.
    Santolaya-Forgas J, Burd LI, Burton BK.
    Fetal Diagn Ther; 1994; 9(6):362-6. PubMed ID: 7880431
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Unexplained elevated midtrimester maternal serum levels of alpha fetoprotein, human chorionic gonadotropin, or low unconjugated estriol: recurrence risk and association with adverse perinatal outcome.
    Wax JR, Lopes AM, Benn PA, Lerer T, Steinfeld JD, Ingardia CJ.
    J Matern Fetal Med; 2000; 9(3):161-4. PubMed ID: 10914623
    [Abstract] [Full Text] [Related]

  • 13. The association of triple-marker test results with adverse pregnancy outcomes in low-risk pregnancies with healthy newborns.
    Sayin NC, Canda MT, Ahmet N, Arda S, Süt N, Varol FG.
    Arch Gynecol Obstet; 2008 Jan; 277(1):47-53. PubMed ID: 17653738
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effect of fetal gender on maternal serum human chorionic gonadotropin levels throughout pregnancy.
    Gol M, Guclu S, Demir A, Erata Y, Demir N.
    Arch Gynecol Obstet; 2005 Dec; 273(2):90-2. PubMed ID: 15991013
    [Abstract] [Full Text] [Related]

  • 17. Elevated maternal serum alpha-fetoprotein with low unconjugated estriol and the risk for lethal perinatal outcome.
    Benn PA, Craffey A, Horne D, Ramsdell L, Rodis JF.
    J Matern Fetal Med; 2000 Dec; 9(3):165-9. PubMed ID: 10914624
    [Abstract] [Full Text] [Related]

  • 18. Mid-trimester triple test levels in early and late onset severe pre-eclampsia.
    Shenhav S, Gemer O, Sassoon E, Volodarsky M, Peled R, Segal S.
    Prenat Diagn; 2002 Jul; 22(7):579-82. PubMed ID: 12124692
    [Abstract] [Full Text] [Related]

  • 19. Confined placental mosaicism for trisomy 14 and maternal uniparental disomy in association with elevated second trimester maternal serum human chorionic gonadotrophin and third trimester fetal growth restriction.
    Towner DR, Shaffer LG, Yang SP, Walgenbach DD.
    Prenat Diagn; 2001 May; 21(5):395-8. PubMed ID: 11360282
    [Abstract] [Full Text] [Related]

  • 20. Preliminary evidence for associations between second-trimester human chorionic gonadotropin and unconjugated oestriol levels with pregnancy outcome in Down syndrome pregnancies.
    Benn PA.
    Prenat Diagn; 1998 Apr; 18(4):319-24. PubMed ID: 9602476
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.